Christodoulos Papadopoulos: Oral Anticoagulation Monotherapy in Chronic Coronary Syndrome
Christodoulos Papadopoulos, Associate Professor in Cardiology at Aristotle University of Thessaloniki, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in European Journal of Preventive Cardiology, adding:
“Our recent meta-analysis on antithrombotic strategy in CCS patients needing oral anticoagulation, nicely executed mainly by Anastasios Tsarouchas.
Major conclusion: OAC monotherapy reduces bleeding while not increasing ischemic events.
Mine interpretation: Try to limit long lasting combination therapy (more than 3 months) especially in frail patients.”
Title: Oral anticoagulant monotherapy vs. combination therapy in patients with chronic coronary syndrome: a systematic review and meta-analysis of randomized trials
Authors: Anastasios Tsarouchas, David Mutschlechner, Maximilian Tscharre, Christodoulos E Papadopoulos, Thomas Gremmel
Stay updated on all scientific advances Hemostasis Today.
-
Oct 12, 2026, 13:58Francisco Chacón-Lozsán: Catastrophic Antiphospholipid Syndrome A Rapidly Progressive Multiorgan Thrombotic Emergency
-
Oct 12, 2026, 12:50Nawsherwan Mohammad: Study Examines Thrombotic Events in Patients with Polycythemia Vera in Iraq
-
Oct 12, 2026, 12:30Chanakya Nayudu: Looking Beyond Blood Clots – Patient-Reported Outcomes in Antiphospholipid Syndrome
-
Oct 12, 2026, 12:12Jean-Jacques Kiladjian: Improving Treatment Strategies with JAK Inhibitors in Myelofibrosis
-
Oct 12, 2026, 12:04Chloe Homich: AABB Annual Meetings – Building Connections and Advancing Transfusion Medicine
-
Oct 12, 2026, 11:51Daniel Sop: Sickle Cell Research Takes Center Stage at ASCAT 2026
-
Oct 12, 2026, 10:36PAI-1 Inhibition as a New Strategy for Enhancing Fibrinolysis and Clot Resolution
-
Oct 12, 2026, 07:39Emmanuel J Favaloro: 100 Years of von Willebrand Disease and the Importance of Local Diagnosis and Management
-
Oct 12, 2026, 07:39Post-Stroke Fatigue Trajectories – 38% Recovered at 12 Months, While 16% Developed New Fatigue – International Journal of Stroke